Parul Doshi

Parul Doshi currently serves as Sr. Director at Gilead Sciences since January 2022. Prior to this role, Parul Doshi held the position of Director at Bristol Myers Squibb, focusing on Lung Cancer as the Translational Medicine Team Leader from October 2017 to January 2022. Parul Doshi's extensive experience in the pharmaceutical industry also includes serving as Director and Scientific Director at Johnson & Johnson, where responsibilities encompassed overseeing preclinical studies in Oncology from October 2005 to January 2022. Earlier career roles include Director positions at Centocor R&D Inc. and Centocor (2005 - January 2022), as well as Associate Director roles at Pfizer Global R&D and Pfizer R&D from 2003 to 2005. Parul Doshi earned a Doctor of Philosophy (Ph.D.) in Biochemistry from Rutgers University.